ASO Visual Abstract: Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia [0.03%]
《ASO视觉摘要：邻里贫困与费城乳腺癌诊断分期和治疗延迟的相关性》
Isabel C Yoon,Stephany Perez-Rojas,Bhavya Ancha et al.
Isabel C Yoon et al.
Quantifying the impact of treatment delays on breast cancer survival outcomes: a comprehensive meta-analysis [0.03%]
量化治疗延误对乳腺癌预后影响的全面meta分析研究
Zoltan Ungvari,Mónika Fekete,Annamaria Buda et al.
Zoltan Ungvari et al.
Treatment delay in breast cancer care represents a significant concern in oncology, potentially impacting patient survival outcomes. While various factors can contribute to delayed treatment initiation, the quantitative relationship between...
Impact of Postoperative Radiation Therapy Delay and Treatment Facility Location on Survival in Head and Neck Cancer Patients [0.03%]
头颈癌患者术后放疗延迟及治疗机构位置对生存的影响
Niketna Vivek,Rahul Sharma,Kavita Prasad et al.
Niketna Vivek et al.
Background: Time from surgery to initiation of postoperative radiation therapy (PORT) of less than 6 weeks was recently instituted as the first quality metric within head and neck cancer care. ...
Oncological outcomes, surgical margins, and adjuvant treatment delays in vulvar cancer patients with or without reconstruction during primary surgery [0.03%]
一期手术中伴有或不伴重建的外阴癌患者的肿瘤结局、切缘及辅助治疗延迟
Milla K Mörsky,Reita H Nyberg,Maarit H Vuento et al.
Milla K Mörsky et al.
Objective: As vulvar reconstruction has been proposed to improve surgical margins and could affect the timing of adjuvant therapy in patients with vulvar cancer, we aimed to compare oncological outcomes, surgical margins,...
Clinical factors associated with delayed ischemic and non-ischemic adverse events in clazosentan therapy after aneurysmal subarachnoid hemorrhage: early insights from a multicenter prospective registry [0.03%]
基于动脉瘤性蛛网膜下腔出血后clazosentan治疗延迟缺血性和非缺血性不良事件的临床因素：多中心前瞻性注册研究早期见解
Taku Sugiyama,Masaaki Hokari,Daisuke Shimbo et al.
Taku Sugiyama et al.
Clazosentan (CLZ) therapy prevents delayed ischemia following aneurysmal subarachnoid hemorrhage (aSAH), but non-ischemic adverse events necessitate optimized protocols. This study presents outcomes of contemporary CLZ therapy under a unifi...
Multicenter Study
Neurosurgical review. 2025 Jun 5;48(1):482. DOI:10.1007/s10143-025-03646-3 2025
Delay in diagnosis and treatment of childhood cancers in a developing country: A cross-sectional patient-based survey at country's largest pediatric oncology center [0.03%]
发展中国家儿童癌症诊断和治疗延误的现状：来自全国最大儿科肿瘤中心的基于患者的数据横断面调查
Rahat Ul Ain,Ali Abdur Rahman,Asfand Tariq et al.
Rahat Ul Ain et al.
Background & objectives: Pediatric cancers have a huge survival gap between the high-income and the low-middle-income countries (LMICs). Despite various other causes, the advanced stage of presentation is a major contribu...
Current Status of Delay in Injectable Therapy among Type 2 Diabetes Mellitus Patients in South Korea: Multicenter Retrospective Study (2015-2021) [0.03%]
韩国2型糖尿病患者注射治疗延迟的现状（2015-2021年多中心回顾性研究）
Jong Han Choi,Min Kyong Moon,Hae Jin Kim et al.
Jong Han Choi et al.
Background: We aimed to assess the therapeutic inertia associated with injectable therapies and the factors influencing glycemic control following these therapies in patients with type 2 diabetes mellitus (T2DM) in South ...
Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study [0.03%]
手术治疗延迟对T1bN1期PTC患者预后短期影响的回顾性队列研究
Hao Gong,Tianyuchen Jiang,Yi Yang et al.
Hao Gong et al.
Background: As the incidence of papillary thyroid carcinoma (PTC) increases, optimal timing for surgical interventions remains undefined. While surgical delays are known to affect prognosis adversely in various cancers, t...
Effect of delayed treatment on survival of patients with head and neck squamous cell cancer [0.03%]
治疗延迟对头颈部鳞癌患者生存的影响
Dongjie He,Yahui Yang,Rui Li et al.
Dongjie He et al.
The impact of prolonged treatment delays on the survival outcomes of patients with head and neck squamous cell cancer (HNSCC) remains controversial. Patients were identified from the Surveillance, Epidemiology, and End Results (SEER) databa...
Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in Giant Cell Arteritis? [0.03%]
托珠单抗治疗巨细胞动脉炎的前期授权会带来不可接受的治疗延迟吗？
Zhuan Jiang,Lillian Barra
Zhuan Jiang
耗时 0.19356 秒，为您在
48223910
条记录里面共找到 2149 篇文章 [XML]